Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPAY
3276
DELISTED
FlexShopper
FPAY
| $430K | ﹤0.01% |
251,600
-66,794
| -21% | -$119K |
|
3277
ProShares UltraPro Russell2000
URTY
$322M
| $429K | ﹤0.01% |
+5,700
| New | +$433K |
|
3278
Compass Diversified
CODI
$758M
| $428K | ﹤0.01% |
18,000
-259,883
| -94% | -$6.5M |
|
3279
Cars.com
CARS
$662M
| $427K | ﹤0.01% |
29,600
-31,800
| -52% | -$489K |
|
3280
WisdomTree US SmallCap Dividend Fund
DES
$2.18B
| $427K | ﹤0.01% |
+13,400
| New | +$428K |
|
3281
InflaRx
IFRX
$250M
| $427K | ﹤0.01% |
233,300
+132,900
| +132% | +$414K |
|
3282
Janus International
JBI
$700M
| $425K | ﹤0.01% |
+47,200
| New | +$479K |
|
|
TRVG
3283
trivago
TRVG
$373M
| $425K | ﹤0.01% |
+36,011
| New | +$406K |
|
3284
AirSculpt Technologies
AIRS
$339M
| $424K | ﹤0.01% |
+31,000
| New | +$428K |
|
3285
B&G Foods
BGS
$287M
| $424K | ﹤0.01% |
15,700
-3,100
| -16% | -$93.2K |
|
3286
US Global Investors
GROW
$35.5M
| $424K | ﹤0.01% |
81,615
-97,000
| -54% | -$507K |
|
3287
Standard BioTools
LAB
$340M
| $422K | ﹤0.01% |
117,500
+100,000
| +571% | +$345K |
|
|
LOVE
3288
DELISTED
LoveSac
LOVE
| $422K | ﹤0.01% |
+7,800
| New | +$374K |
|
|
WTER
3289
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
| $422K | ﹤0.01% |
30,573
+19,473
| +175% | +$288K |
|
3290
OptimumBank Holdings
OPHC
$93.2M
| $421K | ﹤0.01% |
100,000
-32,200
| -24% | -$136K |
|
3291
Smith-Midland
SMID
$144M
| $421K | ﹤0.01% |
23,700
+19,100
| +415% | +$484K |
|
3292
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.51B
| $420K | ﹤0.01% |
12,600
-45,100
| -78% | -$1.42M |
|
|
BXRX
3293
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $420K | ﹤0.01% |
5,938
+5,860
| +7,513% | +$1.08M |
|
3294
Kyndryl
KD
$2.99B
| $419K | ﹤0.01% |
31,900
+2,900
| +10% | +$43.7K |
|
3295
MarketWise
MKTW
$52.5M
| $419K | ﹤0.01% |
4,440
+3,855
| +659% | +$420K |
|
3296
Fidelity Total Bond ETF
FBND
$26.9B
| $418K | ﹤0.01% |
+8,400
| New | +$429K |
|
3297
NCS Multistage Holdings
NCSM
$123M
| $417K | ﹤0.01% |
8,216
+1,000
| +14% | +$44K |
|
3298
Hope Bancorp
HOPE
$1.79B
| $416K | ﹤0.01% |
25,900
-85,964
| -77% | -$1.42M |
|
3299
iShares Silver Trust
SLV
$28B
| $416K | ﹤0.01% |
+18,200
| New | +$405K |
|
3300
PAVmed
PAVM
$35.4M
| $415K | ﹤0.01% |
699
-1,361
| -66% | -$1.01M |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.